These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19399908)

  • 21. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
    Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
    Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic fibrosis: A convergent response to liver injury that is reversible.
    Wang S; Friedman SL
    J Hepatol; 2020 Jul; 73(1):210-211. PubMed ID: 32402525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
    Heim D; Wege H
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):111-21. PubMed ID: 19305371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair.
    Kitto LJ; Henderson NC
    Hepatol Commun; 2021 Mar; 5(3):358-370. PubMed ID: 33681672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Some factors on hepatic stellate cells activation].
    Yang WF; Chen HC; Jiang YP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):121-3. PubMed ID: 14980129
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrosis and cirrhosis reversibility - molecular mechanisms.
    Gieling RG; Burt AD; Mann DA
    Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of Liver Fibrosis.
    Campana L; Iredale JP
    Semin Liver Dis; 2017 Feb; 37(1):1-10. PubMed ID: 28201843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent advances in treating liver fibrosis with mesenchymal stem cells].
    Sun HC; Zhang GZ; Zhang XL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):877-80. PubMed ID: 23405406
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel fate-tracing strategies show that hepatic stellate cells mediate fibrosis in vivo.
    Liang S; Zhong Z; Seki E
    Gastroenterology; 2014 Jun; 146(7):1823-5. PubMed ID: 24768331
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
    Sonoyama T; Tamura N; Miyashita K; Park K; Oyamada N; Taura D; Inuzuka M; Fukunaga Y; Sone M; Nakao K
    FEBS Lett; 2009 Jun; 583(12):2067-70. PubMed ID: 19463821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin in hepatic fibrosis--friend or foe?
    Rockey D
    Hepatology; 1996 Jun; 23(6):1698-700. PubMed ID: 8675196
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.
    Guo CJ; Pan Q; Cheng T; Jiang B; Chen GY; Li DG
    FEBS J; 2009 Sep; 276(18):5163-76. PubMed ID: 19674103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of epithelial cells with hepatobiliary phenotype.
    Castorina S; Luca T; Torrisi A; Privitera G; Panebianco M
    Ital J Anat Embryol; 2008; 113(4):199-207. PubMed ID: 19507460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatic fibrosis tempered by senescent stellate cells].
    Gilgenkrantz H
    Med Sci (Paris); 2009 Feb; 25(2):137-8. PubMed ID: 19239843
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell interactions with the extracellular matrix.
    Bruckner-Tuderman L; von der Mark K; Pihlajaniemi T; Unsicker K
    Cell Tissue Res; 2010 Jan; 339(1):1-5. PubMed ID: 19902257
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease.
    Schotanus BA; van den Ingh TS; Penning LC; Rothuizen J; Roskams TA; Spee B
    Liver Int; 2009 Sep; 29(8):1241-52. PubMed ID: 19490419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic fibrosis: can we treat it clinically?
    Das K; Chowdhury A
    Trop Gastroenterol; 2008; 29(2):76-83. PubMed ID: 18972766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gut.
    Rudich N; Zamir G; Pappo O; Shlomai Z; Faroja M; Weiss ID; Wald H; Galun E; Peled A; Wald O
    Liver Int; 2009 Sep; 29(8):1273-84. PubMed ID: 19538448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Connective tissue metabolism and hepatic fibrosis: an overview.
    Bissell DM
    Semin Liver Dis; 1990 Feb; 10(1):iii-iv. PubMed ID: 2186484
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein A1 and hepatic fibrosis.
    Poynard T; Bedossa P; Mathurin P; Ratziu V; Paradis V
    J Hepatol; 1995; 22(2 Suppl):107-10. PubMed ID: 7665844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.